On October 21st, Sanofi announced it has entered into exclusive negotiations with CD&R to sell a controlling stake in Opella. This announcement is a major and exciting milestone on our …

3 days ago · The decision to divest Opella is part of Sanofi’s ongoing strategy to become a pureplay biopharma company. Opella employs more than 11,000 people worldwide and is …

3 days ago · Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale …

3 days ago · Sanofi and CD&R sign Opella share purchase agreement. Paris, February 19, 2025.Following completion of the required social and corporate procedures, Sanofi and CD&R …

Oct 30, 2024 · Opella is Sanofi’s consumer healthcare business unit focusing on over-the-counter medicines, vitamins, minerals, and supplements and includes brands such as Allegra, …

Oct 21, 2024 · Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have …

Oct 21, 2005 · Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have …

Oct 11, 2006 · Sanofi in discussions to sell a controlling stake in Opella. Paris, October 11, 2024. Sanofi today announces that the company has entered into negotiations with CD&R for the …

Oct 21, 2024 · French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm …

Oct 21, 2024 · Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have …